Cencora, Inc. $COR Shares Bought by Trajan Wealth LLC

Trajan Wealth LLC raised its position in Cencora, Inc. (NYSE:COR) by 6.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 143,475 shares of the company’s stock after purchasing an additional 8,169 shares during the quarter. Cencora comprises 2.0% of Trajan Wealth LLC’s investment portfolio, making the stock its 11th biggest position. Trajan Wealth LLC owned 0.07% of Cencora worth $48,459,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Algebris UK Ltd. boosted its holdings in Cencora by 5.7% in the 4th quarter. Algebris UK Ltd. now owns 5,751 shares of the company’s stock valued at $1,943,000 after purchasing an additional 311 shares during the last quarter. Leonteq Securities AG acquired a new position in Cencora in the 4th quarter valued at about $58,000. ABN Amro Investment Solutions boosted its holdings in Cencora by 289.2% in the 4th quarter. ABN Amro Investment Solutions now owns 8,648 shares of the company’s stock valued at $2,921,000 after purchasing an additional 6,426 shares during the last quarter. IFP Advisors Inc boosted its holdings in Cencora by 40.2% in the 4th quarter. IFP Advisors Inc now owns 3,939 shares of the company’s stock valued at $1,330,000 after purchasing an additional 1,130 shares during the last quarter. Finally, First Business Financial Services Inc. boosted its holdings in Cencora by 3.0% in the 4th quarter. First Business Financial Services Inc. now owns 13,742 shares of the company’s stock valued at $4,641,000 after purchasing an additional 398 shares during the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. UBS Group boosted their target price on shares of Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Weiss Ratings reissued a “buy (b)” rating on shares of Cencora in a research note on Monday, May 4th. Barclays boosted their price target on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. Citigroup cut their target price on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research note on Thursday, May 7th. Finally, Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $380.25.

Cencora Trading Down 0.5%

Shares of NYSE:COR opened at $264.79 on Thursday. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54. The company’s 50 day moving average is $308.93 and its two-hundred day moving average is $337.71. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40. The company has a market cap of $51.52 billion, a PE ratio of 20.31, a P/E/G ratio of 1.23 and a beta of 0.64.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The company had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same quarter in the previous year, the company posted $4.42 EPS. The company’s quarterly revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Equities analysts predict that Cencora, Inc. will post 17.76 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Friday, May 15th will be issued a $0.60 dividend. The ex-dividend date is Friday, May 15th. This represents a $2.40 annualized dividend and a dividend yield of 0.9%. Cencora’s dividend payout ratio is presently 18.40%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.